Bespoke Extracts (BSPK) Cash from Investing Activities (QoQ) (2013 - 2022)
Bespoke Extracts (BSPK) Cash from Investing Activities (QoQ) (2013 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -10,445.20% |
| Sep 30, 2022 | 107.47% |
| Jun 30, 2022 | 81.35% |
| Feb 28, 2021 | -1.82% |
| Aug 31, 2017 | 14,250.94% |
| May 31, 2014 | 75.36% |
| Feb 28, 2014 | 52.15% |
| Nov 30, 2013 | -8.81% |
| Aug 31, 2013 | 13.96% |
| May 31, 2013 | 0.00% |
| Feb 28, 2013 | 0.00% |